In the November 15 issue of IBO, the article entitled “M&A Flurry Amidst Rising Valuations,” PerkinElmer was incorrectly identified as having sold its NIPT screening lab services business. The first part of the sentence should have read: “Interestingly, such divestments included two testing services businesses: PerkinElmer’s US prenatal screening laboratory services business (see IBO 4/30/16).”